• Depot
  • Watchlist
  • Glocke
  • Handeln

    • Ocular Therapeutix Inc News

    4,745 $ +12,98% +0,545 $
    In : 4,4375 € | 26.04.24 22:00:00 Nasdaq aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A1180P
    ISIN: US67576A1007
    US-Symbol: OCUL
    Typ: Aktie

    Ocular Therapeutix Inc News

    19.02.24 - PR Newswire
    AffaMed Therapeutics Announces New Drug Application Acceptance by Singapore Health Sciences Authority (HSA) for DEXTENZA® for Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery, and Ocular Itching Associated with Allergic Conjunctivitis
    AffaMed Therapeutics Announces New Drug Application Acceptance by Singapore Health Sciences Authority (HSA) for DEXTENZA® for Treatment of Ocular Inflammation and Pain ...
    12.02.24 - PR Newswire
    Thinking about buying stock in Meta Platforms, Ocular Therapeutix, Phathom Pharmaceuticals, Revelation Biosciences, or Sunworks?
    Thinking about buying stock in Meta Platforms, Ocular Therapeutix, Phathom Pharmaceuticals, Revelation Biosciences, or Sunworks? PR Newswire
    31.10.23 - PR Newswire
    AffaMed Therapeutics Announced Positive Top-Line Results from Real-World Study in China Evaluating the Safety and Efficacy of DEXTENZA® in Patients after Cataract Surgery
    AffaMed Therapeutics Announced Positive Top-Line Results from Real-​World Study in China Evaluating the Safety and Efficacy of DEXTENZA® in Patients after Cataract Surgery PR ...
    27.09.22 - PR Newswire
    Thinking about buying stock in Equillium, Marathon Digital, Missfresh, Ocular Therapeutix, or Riot Blockchain?
    Thinking about buying stock in Equillium, Marathon Digital, Missfresh, Ocular Therapeutix, or Riot Blockchain? PR Newswire
    12.04.22 - PR Newswire
    AffaMed Therapeutics Announces New Drug Approval for DEXTENZA in Macau for the Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery
    AffaMed Therapeutics Announces New Drug Approval for DEXTENZA in Macau for the Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery PR Newswire
    29.11.21 - The Motley Fool
    3 Small-Cap-Aktien, die jetzt für langfristige Anleger ein Kauf sind
    Wichtige Punkte Renalytix vermarktet einen Diagnoseservice, der dem US-​Service Medicare jedes Jahr Milliarden einsparen könnte. Ocular Therapeutix stellt eine ...
    23.07.21 - PR Newswire
    Thinking about buying stock in Acorda Therapeutics, Ocular Therapeutix, Ocugen, Aerpio Pharmaceuticals, or Anavex Life Sciences?
    Thinking about buying stock in Acorda Therapeutics, Ocular Therapeutix, Ocugen, Aerpio Pharmaceuticals, or Anavex Life Sciences? PR Newswire
    16.02.21 - PR Newswire
    Thinking about buying stock in Salarius Pharmaceuticals, KemPharm, Ocular Therapeutix, Boxlight Corp, or Endra Life Sciences?
    Thinking about buying stock in Salarius Pharmaceuticals, KemPharm, Ocular Therapeutix, Boxlight Corp, or Endra Life Sciences? PR Newswire
    17.06.20 - PR Newswire
    Thinking about buying stock in Celsion Corp, Alkaline Water Company, Salem Media Group, Ocular Therapeutix, or Delta Air Lines?
    Thinking about buying stock in Celsion Corp, Alkaline Water Company, Salem Media Group, Ocular Therapeutix, or Delta Air Lines? PR Newswire
    15.05.20 - PR Newswire
    Thinking about buying stock in VBI Vaccines, Aphria, Ocular Therapeutix, New Age Beverages, or General Electric?
    Thinking about buying stock in VBI Vaccines, Aphria, Ocular Therapeutix, New Age Beverages, or General Electric? PR Newswire
    28.04.20 - PR Newswire
    Thinking about buying stock in Aytu Bioscience, SmileDirectClub, Ocular Therapeutix, Six Flags Entertainment, or MGM Resorts?
    Thinking about buying stock in Aytu Bioscience, SmileDirectClub, Ocular Therapeutix, Six Flags Entertainment, or MGM Resorts? PR Newswire
    31.08.17 - PR Newswire
    EQUITY ALERT UPDATE: Rosen Law Firm Announces Filing of Securities Class Action Against Ocular Therapeutix, Inc. - OCUL
    EQUITY ALERT UPDATE: Rosen Law Firm Announces Filing of Securities Class Action Against Ocular Therapeutix, Inc. - OCUL PR Newswire
    25.08.17 - PR Newswire
    Bernstein Liebhard LLP Announces That Only 10 Days Remain To File A Motion For Lead Plaintiff In A Class Action Filed Against Ocular Therapeutix, Inc.
    Bernstein Liebhard LLP Announces That Only 10 Days Remain To File A Motion For Lead Plaintiff In A Class Action Filed Against Ocular Therapeutix, Inc. PR Newswire
    25.07.17 - PR Newswire
    Block & Leviton Reminds Ocular Therapeutix, Inc. (OCUL) Shareholders Of Important Deadline In Securities Fraud Class Action And Encourages Them To Contact The Firm
    Block & Leviton Reminds Ocular Therapeutix, Inc. (OCUL) Shareholders Of Important Deadline In Securities Fraud Class Action And Encourages Them To Contact The Firm PR ...
    25.07.17 - PR Newswire
    OCUL Investors Update: Hagens Berman Alerts Investors in Ocular Therapeutix, Inc. to Expanded Class Period in Pending Securities Class Action, Reminds Them of the September 5, 2017 Lead Plaintiff Dead
    OCUL Investors Update: Hagens Berman Alerts Investors in Ocular Therapeutix, Inc. to Expanded Class Period in Pending Securities Class Action, Reminds Them of the ...
    24.07.17 - PR Newswire
    Lifshitz & Miller LLP Announces Investigation of Acacia Communications, Inc., AngioDynamics, Inc., ClubCorp Holdings, Inc., HD Supply Holdings, Inc., Ocular Therapeutix, Inc., Repros Therapeutics
    Lifshitz & Miller LLP Announces Investigation of Acacia Communications, Inc., AngioDynamics, Inc., ClubCorp Holdings, Inc., HD Supply Holdings, Inc., Ocular Therapeutix, Inc., ...
    21.07.17 - PR Newswire
    SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ocular Therapeutix, Inc. of Class Action Lawsuit and Upcoming Deadline - OCUL
    SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ocular Therapeutix, Inc. of Class Action Lawsuit and Upcoming Deadline - ...
    19.07.17 - PR Newswire
    OCULAR THERAPEUTIX ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ocular Therapeutix, Inc. To Contact The Firm
    OCULAR THERAPEUTIX ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ocular Therapeutix, Inc. To Contact The Firm PR Newswire
    19.07.17 - PR Newswire
    Investor Alert: Kaplan Fox Announces Investigation Of Ocular Therapeutix, Inc.
    Investor Alert: Kaplan Fox Announces Investigation Of Ocular Therapeutix, Inc. PR Newswire
    12.07.17 - PR Newswire
    IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Ocular Therapeutix, Inc. and Encourages Investors with Losses to Contact the Firm
    IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Ocular Therapeutix, Inc. and Encourages Investors with Losses to ...

    Newssuche

    Videos

    newspaper
    26.04.24 +6,31%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »